MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Use of syringe driver in End of Life Care in Parkinson’s Disease (PD)

    N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)

  • Usefulness of Cardiac MIBG Scintigraphy, DAT scan and midbrain/pontine ratio to differentiate Parkinson disease from atypical parkinsonian syndrome

    H. Fujita, K. Suzuki, Y. Watanabe, M. Hamaguchi, K. Hirata (Mibu, Japan)

  • Usefulness of Heart Rate Variability to Identify the Risk of Falling in Huntington’s Disease

    C. Terroba-Chambi, D. Vigo, M. Merello (Buenos Aires, Argentina)

  • Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, R. Weil (London, United Kingdom)

  • Using cognitive computing to identify existing drugs with potential to stabilize mitophagy pathways associated with Parkinson’s Disease

    N. Visanji, N. Moskal, G. Shi, A. Lacoste, S. Spangler, P. Lewis, A. Mcquibban (Toronto, ON, Canada)

  • Using functional status to aid interpretation of cUHDRS scores in patients with Huntington’s disease

    D. Trundell, G. Palermo, J. Long, B. Leavitt, S. Schobel, S. Tabrizi (Welwyn Garden City, United Kingdom)

  • Using Quantitative Susceptibility Mapping to Predict Dementia in Parkinson’s Disease

    G. Thomas, L. Leyland, J. Acosta-Cabronero, R. Weil (London, United Kingdom)

  • Using whole genome sequencing and intronic sequence analysis to identify pathogenic variants in Parkin-related Parkinson’s Disease

    R. Davis, K. Kumar, F. Edema-Hildebrand, J-S. Park, B. Koentjoro, V. Gayevskiy, M. Cowley, N. Blair, C. Sue (St Leonards, Australia)

  • Utilising Magnetic Resonance Spectroscopy to investigate synucleinopathies

    N. Khalil, E. Matar, S. Duffy, S. Lewis (Camperdown, Australia)

  • Utility of a smartphone app in discretely assessing and monitoring symptoms of Parkinson’s disease

    N. Shaafi Kabiri, A. Best, S. Johnson, B. Ho, G. Eden, B. Dupee, M. Fedorovsky, J. Severson, D. Amato, B. Severson, J. Bhangu, J. Cosman, M. Erb, K. Thomas (Boston, MA, USA)

  • « Previous Page
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #26133 (not found)
  • #23951 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Carpal Tunnel Syndrome in Patients with Tremor
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley